Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hiddemann

Showing results (111-120 of 533) with videos related to

Pageof 54
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 24, 2006
[Acute myeloid leukemia -- on the way towards pathogenesis-oriented treatment]K Metzeler, S Fritsch, C Buske, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000
Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cellsC Binder, M Schulz, W Hiddemann, et al.
Deutsche Medizinische Wochenschrift (1946)|April 13, 2000
[The therapy of testicular tumors 2 decades after the introduction of cisplatin]A Gerl, H Sauer, B Liedl, et al.
Biotechniques|December 1, 1995
Short technical reports. Quantification of ribozyme-mediated RNA cleavage using silver-stained polyacrylamide gelsK Palfner, M Kneba, W Hiddemann, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromesW Verbeek, K Vehmeyer, B Wörmann, et al.
Der Internist|December 1, 1996
[Prevention, diagnosis and therapy of infections in patients with malignant diseases]W Hiddemann, G Maschmeyer, V Runde, et al.
Blut|March 1, 1974
[Preparation of blood and bone marrow cells for impulse cytophotometry]T Büchner, W Hiddemann, R Schneider, et al.
Journal of Internal Medicine. Supplement|January 1, 1997
Treatment of follicular follicle centre lymphomas: current status and future perspectivesW Hiddemann, M Unterhalt, C Buske, et al.
Leukemia|March 23, 2007
The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factorsM Weisser, C Haferlach, W Hiddemann, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2006
[Diagnostics and therapy of acute myeloid leukemia]S Fritsch, K Metzeler, W Hiddemann, et al.
Pageof 54

Showing results (111-120 of 533) with videos related to

Sort By:
Pageof 54
Deutsche Medizinische Wochenschrift (1946)|June 24, 2006
[Acute myeloid leukemia -- on the way towards pathogenesis-oriented treatment]K Metzeler, S Fritsch, C Buske, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2000
Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cellsC Binder, M Schulz, W Hiddemann, et al.
Deutsche Medizinische Wochenschrift (1946)|April 13, 2000
[The therapy of testicular tumors 2 decades after the introduction of cisplatin]A Gerl, H Sauer, B Liedl, et al.
Biotechniques|December 1, 1995
Short technical reports. Quantification of ribozyme-mediated RNA cleavage using silver-stained polyacrylamide gelsK Palfner, M Kneba, W Hiddemann, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromesW Verbeek, K Vehmeyer, B Wörmann, et al.
Der Internist|December 1, 1996
[Prevention, diagnosis and therapy of infections in patients with malignant diseases]W Hiddemann, G Maschmeyer, V Runde, et al.
Blut|March 1, 1974
[Preparation of blood and bone marrow cells for impulse cytophotometry]T Büchner, W Hiddemann, R Schneider, et al.
Journal of Internal Medicine. Supplement|January 1, 1997
Treatment of follicular follicle centre lymphomas: current status and future perspectivesW Hiddemann, M Unterhalt, C Buske, et al.
Leukemia|March 23, 2007
The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factorsM Weisser, C Haferlach, W Hiddemann, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2006
[Diagnostics and therapy of acute myeloid leukemia]S Fritsch, K Metzeler, W Hiddemann, et al.
Pageof 54